Cannabinoid receptor 1 activity promotes microbial dysbiosis by stimulating the oxygen-dependent expansion of Enterobacteriaceae

Inside the human gut, a vast and intricate ecosystem of bacteria lives in a delicate balance. For this community to thrive, the environment must remain almost entirely devoid of oxygen, a condition known as anoxia. This oxygen-free state is maintained by the cells lining the intestine, which act like a sponge, consuming oxygen as they process nutrients. This consumption keeps the gut dark and airless, a perfect home for the beneficial, oxygen-hating bacteria that help digest food and protect the body. When this balance is disrupted, oxygen leaks into the gut, allowing different types of bacteria—those that can breathe oxygen—to multiply rapidly. This shift often leads to inflammation and disease, a state scientists call dysbiosis. Researchers have long known that the body's own chemical signals, specifically a system involving fatty molecules that regulate pain and appetite, play a role in gut health. However, the precise way these signals interact with the bacteria and the oxygen levels in the gut has remained a mystery.

A new study by researchers at the University of South Carolina and the University of Texas at Austin has uncovered a surprising link between these chemical signals and the oxygen levels in the gut. The team focused on a specific receptor in the body called CB1, which is part of the endocannabinoid system. While this system is often discussed in the context of pain relief or appetite, the researchers discovered that when CB1 is overactive in the colon, it causes the lining of the gut to stop consuming oxygen efficiently. This failure allows oxygen to seep into the gut lumen, creating an environment where harmful bacteria can flourish. The study suggests that this mechanism might be a key factor in the development of inflammatory bowel diseases, such as Crohn's disease, where patients often show both high levels of these chemical signals and an overgrowth of specific bacteria.

To investigate this, the researchers used mice that were free of the specific bacteria usually found in the human gut. They first introduced a common, harmless strain of Escherichia coli into these mice. Then, they administered a drug that blocks the breakdown of a natural fatty molecule called 2-arachidonoyl glycerol, or 2-AG. This molecule normally signals through the CB1 receptor. By blocking its breakdown, the researchers effectively increased the amount of 2-AG in the mice's guts, simulating a state of high endocannabinoid activity. Within just twelve hours, the mice treated with the drug showed a massive explosion in the number of E. coli bacteria in their feces. The bacteria increased by orders of magnitude, a level of growth that did not happen in the control mice who received a harmless placebo.

The team then asked whether this bacterial growth was caused by the bacteria sensing the fatty molecule directly, or if it was a result of changes in the mouse's own body. They tested this by using a mutant strain of bacteria that could not sense the molecule. The bacteria still grew wildly, proving that the effect was not due to the bacteria reacting to the chemical signal. Instead, the growth was driven by the mouse's own tissues. When the researchers blocked the CB1 receptor in the mice, either with a drug or by using mice genetically engineered to lack the receptor, the bacterial explosion stopped completely. This confirmed that the CB1 receptor in the host animal was the driver of the change.

Digging deeper, the researchers examined what was happening inside the cells of the mouse colon. They found that activating the CB1 receptor caused the cells to show signs of stress and a drop in their energy production. Specifically, the cells' mitochondria, which are the power plants of the cell, began to malfunction. This malfunction led to a significant decrease in the amount of energy the cells could produce. Because the cells were no longer consuming oxygen efficiently to generate energy, oxygen began to accumulate and diffuse into the gut. This influx of oxygen created a new environment that favored the growth of E. coli and other bacteria that can breathe oxygen. The researchers confirmed this by showing that when they blocked the specific genes in the bacteria that allow them to use oxygen, the bacteria could no longer grow even when the mouse's CB1 receptor was active.

The study also looked at what happens in mice that are genetically prone to developing chronic gut inflammation, similar to humans with Crohn's disease. In these susceptible mice, the same activation of the CB1 receptor led to an even more severe disruption. The bacteria not only multiplied in the gut but also invaded the tissue lining the intestine, causing significant inflammation and damage. The researchers found that this process was accelerated when the CB1 receptor was active, leading to a faster and more severe disease course. Conversely, when they blocked the receptor, the infection was contained, and the tissue damage was reduced.

These findings challenge the previous understanding that the endocannabinoid system is always protective against gut inflammation. While it is true that in some contexts, increasing these signals can help heal the gut, this study shows that in a healthy gut, a sudden spike in activity can actually trigger the very conditions that lead to disease. The researchers demonstrated that the activation of the CB1 receptor disrupts the metabolic engine of the gut lining, turning a safe, oxygen-free zone into a breeding ground for potentially harmful bacteria. This discovery provides a new explanation for why patients with inflammatory bowel disease often have high levels of these chemical signals and an overgrowth of specific bacteria. It suggests that the body's own signaling system, when dysregulated, can inadvertently sabotage the delicate balance of the gut microbiome, paving the way for chronic illness. The work highlights a complex interplay where a signal meant to regulate the body can, under the wrong conditions, trigger a chain reaction that compromises the entire ecosystem of the gut.